Stanko
Stanko Bezek, Varazdin HR
Patent application number | Description | Published |
---|---|---|
20120037260 | TUBE FLOW TURBULATOR - The tube flow turbulator, type TC-09/A-B is a unique invention, resulted from work in measuring and regulation technology, and resolving problems in this field of work. The tube flow turbulator solves the problem of dirt collection in control assemblies and enhances operation of a dirt collector. The advantage of the tube flow turbulator is that maximally reduces necessity for human intervention, and resolves problems in cases where there are no dirt collectors. It is simply installed in a closed pipeline system, between pipeline and control assembly flanges with two seals. | 02-16-2012 |
Stanko Hocevar, Ljubljana SI
Patent application number | Description | Published |
---|---|---|
20130045866 | ELECTROCATALYTIC COMPOSITE(S), ASSOCIATED COMPOSITION(S), AND ASSOCIATED PROCESS(ES) - Compositions having electrocatalytic activity and composites having electrocatalytic activity, as well as processes for making compositions and composites are described. Also, processes for using such compositions and/or composites, such as, for example, a machine or equipment are described. Some aspects of embodiments and/or embodiments of the present invention are directed to a nanosize transition metal alloy (such as for example an alloy and/or one or more intermetallics comprising copper, cobalt, nickel, palladium, platinum, ruthenium, the like, and combinations thereof) that is electrocatalytically active. Some other aspects of embodiments and/or embodiments of the present invention are directed to a composite material comprising a nanosize transition metal alloy and a carbonaceous matrix. | 02-21-2013 |
Stanko Jelavic, Davie, FL US
Patent application number | Description | Published |
---|---|---|
20150118986 | METHOD AND APPARATUS FOR MITIGATING RADIO FREQUENCY INTERFERENCE (RFI) IN AN ELECTRICAL DEVICE - A method and circuit for mitigating RFI in an electronic device that occurs while the device is in a low power mode utilizes one or more antenna elements in the device to receive RF energy. When the RF energy is sufficiently high that it could affect signal states in the device while in the low power mode, the device transitions from the low power mode to an active mode and begins an RFI mitigation process to ensure signal states and other circuit operations in the device are not changed by the RFI. | 04-30-2015 |
Stanko Skrtic, Goteborg SE
Patent application number | Description | Published |
---|---|---|
20090035375 | Pharmaceutical compositions for acute glucocorticoid therapy - The present invention relates to glucocorticoid-containing pharmaceutical compositions or kits for use in acute emergency situations where acute glucocorticoid therapy is required. Notably, the invention relates to pharmaceutical compositions and kits that are designed to be administered by non-medically trained persons outside a hospital or another medical or clinical setting. The invention also relates to a method for treating a disorder requiring acute glucocorticoid therapy by providing a fast onset of action of a glucocorticoid | 02-05-2009 |
20100062981 | USE OF FIBRINOGEN AS A PROPHYLACTIC TREATMENT TO PREVENT BLEEDING DURING AND AFTER SURGERY AND AS A BIOMARKER TO IDENTIFY PATIENT WITH AN INCREASED RISK FOR EXCESSIVE BLEEDING AND BLOOD TRANSFUSION - The present invention provides a method for preventing peri- and postoperative bleeding in subjects undergoing surgery, in particular subjects with a preoperative fibrinogen plasma level equal to or above the normal range. The method comprises administration of a substance with fibrinogen-like activity to the subject in an amount that result in a circulating fibrinogen plasma level of from about 1.0 g/L. The present invention also provides a method for determining the risk of subjects with a preoperative fibrinogen plasma level equal to or above the normal range to bleed postoperatively. Furthermore, the present invention provides means for predicting the necessity of blood or plasma transfusion after a subject with a preoperative fibrinogen plasma level equal to or above the normal range has been subject to a surgical procedure. The means involves measurement of the fibrinogen level of the subject before surgery and comparing the level with a risk curve. | 03-11-2010 |
20120183610 | GLUCOCORTICOID THERAPY - The present invention relates to improved glucocorticoid therapy and to treatment or prevention of a number of disorders that are due to a diminished or disrupted endogenous glucocorticoid secretory pattern. The invention is based on the findings that producing a specific serum Cortisol time profile that mimics the circadian rhythm of Cortisol of a healthy subject in a subject suffering from a diminished or disrupted glucocorticoid secretory pattern gives benefits with respect to reduction of side-effects. | 07-19-2012 |
Stanko Skrtic, Molndal SE
Patent application number | Description | Published |
---|---|---|
20130129823 | PHARMACEUTICAL COMPOSITIONS FOR GLUCOCORTICOID REPLACEMENT THERAPY - The invention relates to glucocorticoid replacement therapy and provides pharmaceutical compositions and kits designed to deliver one or more glucocorticoids to a subject in need thereon in a manner that results in serum levels of the glucocorticoid that essentially mimic that of a healthy subject for a clinically relevant period of time. The pharmaceutical compositions and kits are prepared in such a way that a first part of one or more glucocorticoids is substantially immediately released and a second part of one or more glucocorticoids is released over an extended period of time of at least about 8 hours. The invention also relates to a method for treating diseases requiring glucocorticoid treatment such as in subjects having a glucocorticoid deficiency disorder. | 05-23-2013 |
20130209565 | POSOLOGY AND ADMINISTRATION OF GLUCOCORTICOID BASED COMPOSITIONS - The present invention relates to an improved method of administration of glucocorticoid based compositions in glucocorticoid replacement therapies enabling an objectively based regimen for administration enabling correct individual dosing of glucocorticoids resulting in an optimised individual replacement therapy and thus an improved long-term outcome for patients with temporary or chronic adrenal insufficiency. | 08-15-2013 |
20140242167 | PHARMACEUTICAL COMPOSITIONS FOR GLUCOCORTICOID REPLACEMENT THERAPY - The invention relates to glucocorticoid replacement therapy and provides pharmaceutical compositions and kits designed to deliver one or more glucocorticoids to a subject in need thereon in a manner that results in serum levels of the glucocorticoid that essentially mimic that of a healthy subject for a clinically relevant period of time. The pharmaceutical compositions and kits are prepared in such a way that a first part of one or more glucocorticoids is substantially immediately released and a second part of one or more glucocorticoids is released over an extended period of time of at least about 8 hours. The invention also relates to a method for treating diseases requiring glucocorticoid treatment such as in subjects having a glucocorticoid deficiency disorder. | 08-28-2014 |
Stanko Srcic, Ljubljana SI
Patent application number | Description | Published |
---|---|---|
20100172969 | HOT-MELT MICROPELLETS - The present invention provides a method of making solid micropellets of which at least 75% by weight have a diameter less than 500 μm comprising (i) melting one or more binders; and (ii) combining the one or more binders melted in step (i) with a pharmaceutically active ingredient to form solid micropellets. Solid micropellets obtainable by this method are also provided. The invention has particular utility for improving the solubility of poorly water-soluble pharmaceutically active ingredients. | 07-08-2010 |
20110315079 | Process Device for Coating Particles - The subject of the invention is a process device for coating particles that falls within the field of chemical and pharmaceutical technology. It represents an improvement on the process equipment for coating particles by spraying from the bottom and works on the principle of fluidization technology. The process device for coating particles, according to the invention which has within the wall ( | 12-29-2011 |